Global Gene Therapy in CNS Disorder Supply, Demand and Key Producers, 2023-2029
The global Gene Therapy in CNS Disorder market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.
This report studies the global Gene Therapy in CNS Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy in CNS Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy in CNS Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy in CNS Disorder total market, 2018-2029, (USD Million)
Global Gene Therapy in CNS Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy in CNS Disorder total market, key domestic companies and share, (USD Million)
Global Gene Therapy in CNS Disorder revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy in CNS Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy in CNS Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy in CNS Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird Bio Inc. and Biogen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy in CNS Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy in CNS Disorder Market, By Region:
1. How big is the global Gene Therapy in CNS Disorder market?
2. What is the demand of the global Gene Therapy in CNS Disorder market?
3. What is the year over year growth of the global Gene Therapy in CNS Disorder market?
4. What is the total value of the global Gene Therapy in CNS Disorder market?
5. Who are the major players in the global Gene Therapy in CNS Disorder market?
6. What are the growth factors driving the market demand?
Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.
This report studies the global Gene Therapy in CNS Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy in CNS Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy in CNS Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy in CNS Disorder total market, 2018-2029, (USD Million)
Global Gene Therapy in CNS Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy in CNS Disorder total market, key domestic companies and share, (USD Million)
Global Gene Therapy in CNS Disorder revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy in CNS Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy in CNS Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy in CNS Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird Bio Inc. and Biogen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy in CNS Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy in CNS Disorder Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Gene Therapy
- Non-viral Gene Therapy
- Alzheimer's Disease
- Huntington's Disease
- Parkinson's Disease
- Batten Disease
- Voyager Therapeutics
- Spark Therapeutics
- Novartis AG
- Bluebird Bio Inc.
- Biogen
1. How big is the global Gene Therapy in CNS Disorder market?
2. What is the demand of the global Gene Therapy in CNS Disorder market?
3. What is the year over year growth of the global Gene Therapy in CNS Disorder market?
4. What is the total value of the global Gene Therapy in CNS Disorder market?
5. Who are the major players in the global Gene Therapy in CNS Disorder market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Therapy in CNS Disorder Introduction
1.2 World Gene Therapy in CNS Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Therapy in CNS Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy in CNS Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.3 China Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.4 Europe Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.5 Japan Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.6 South Korea Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.7 ASEAN Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.8 India Gene Therapy in CNS Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy in CNS Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy in CNS Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.2 World Gene Therapy in CNS Disorder Consumption Value by Region
2.2.1 World Gene Therapy in CNS Disorder Consumption Value by Region (2018-2023)
2.2.2 World Gene Therapy in CNS Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.4 China Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.5 Europe Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.6 Japan Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.7 South Korea Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.8 ASEAN Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.9 India Gene Therapy in CNS Disorder Consumption Value (2018-2029)
3 WORLD GENE THERAPY IN CNS DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy in CNS Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy in CNS Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in CNS Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in CNS Disorder in 2022
3.3 Gene Therapy in CNS Disorder Company Evaluation Quadrant
3.4 Gene Therapy in CNS Disorder Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy in CNS Disorder Market: Region Footprint
3.4.2 Gene Therapy in CNS Disorder Market: Company Product Type Footprint
3.4.3 Gene Therapy in CNS Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy in CNS Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy in CNS Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy in CNS Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Therapy in CNS Disorder Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy in CNS Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy in CNS Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Therapy in CNS Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
4.4 China Based Companies Gene Therapy in CNS Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Therapy in CNS Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
4.5 Rest of World Based Gene Therapy in CNS Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy in CNS Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
5.3.2 World Gene Therapy in CNS Disorder Market Size by Type (2024-2029)
5.3.3 World Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy in CNS Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Alzheimer's Disease
6.2.2 Huntington's Disease
6.2.3 Parkinson's Disease
6.2.4 Batten Disease
6.2.5 Batten Disease
6.3 Market Segment by Application
6.3.1 World Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
6.3.2 World Gene Therapy in CNS Disorder Market Size by Application (2024-2029)
6.3.3 World Gene Therapy in CNS Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Voyager Therapeutics
7.1.1 Voyager Therapeutics Details
7.1.2 Voyager Therapeutics Major Business
7.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Product and Services
7.1.4 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Voyager Therapeutics Recent Developments/Updates
7.1.6 Voyager Therapeutics Competitive Strengths & Weaknesses
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Details
7.2.2 Spark Therapeutics Major Business
7.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Product and Services
7.2.4 Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Spark Therapeutics Recent Developments/Updates
7.2.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Gene Therapy in CNS Disorder Product and Services
7.3.4 Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Bluebird Bio Inc.
7.4.1 Bluebird Bio Inc. Details
7.4.2 Bluebird Bio Inc. Major Business
7.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product and Services
7.4.4 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bluebird Bio Inc. Recent Developments/Updates
7.4.6 Bluebird Bio Inc. Competitive Strengths & Weaknesses
7.5 Biogen
7.5.1 Biogen Details
7.5.2 Biogen Major Business
7.5.3 Biogen Gene Therapy in CNS Disorder Product and Services
7.5.4 Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Biogen Recent Developments/Updates
7.5.6 Biogen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy in CNS Disorder Industry Chain
8.2 Gene Therapy in CNS Disorder Upstream Analysis
8.3 Gene Therapy in CNS Disorder Midstream Analysis
8.4 Gene Therapy in CNS Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Therapy in CNS Disorder Introduction
1.2 World Gene Therapy in CNS Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Therapy in CNS Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy in CNS Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.3 China Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.4 Europe Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.5 Japan Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.6 South Korea Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.7 ASEAN Gene Therapy in CNS Disorder Market Size (2018-2029)
1.3.8 India Gene Therapy in CNS Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy in CNS Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy in CNS Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.2 World Gene Therapy in CNS Disorder Consumption Value by Region
2.2.1 World Gene Therapy in CNS Disorder Consumption Value by Region (2018-2023)
2.2.2 World Gene Therapy in CNS Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.4 China Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.5 Europe Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.6 Japan Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.7 South Korea Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.8 ASEAN Gene Therapy in CNS Disorder Consumption Value (2018-2029)
2.9 India Gene Therapy in CNS Disorder Consumption Value (2018-2029)
3 WORLD GENE THERAPY IN CNS DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy in CNS Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy in CNS Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in CNS Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in CNS Disorder in 2022
3.3 Gene Therapy in CNS Disorder Company Evaluation Quadrant
3.4 Gene Therapy in CNS Disorder Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy in CNS Disorder Market: Region Footprint
3.4.2 Gene Therapy in CNS Disorder Market: Company Product Type Footprint
3.4.3 Gene Therapy in CNS Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy in CNS Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy in CNS Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy in CNS Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Therapy in CNS Disorder Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy in CNS Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy in CNS Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Therapy in CNS Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
4.4 China Based Companies Gene Therapy in CNS Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Therapy in CNS Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
4.5 Rest of World Based Gene Therapy in CNS Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy in CNS Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
5.3.2 World Gene Therapy in CNS Disorder Market Size by Type (2024-2029)
5.3.3 World Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy in CNS Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Alzheimer's Disease
6.2.2 Huntington's Disease
6.2.3 Parkinson's Disease
6.2.4 Batten Disease
6.2.5 Batten Disease
6.3 Market Segment by Application
6.3.1 World Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
6.3.2 World Gene Therapy in CNS Disorder Market Size by Application (2024-2029)
6.3.3 World Gene Therapy in CNS Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Voyager Therapeutics
7.1.1 Voyager Therapeutics Details
7.1.2 Voyager Therapeutics Major Business
7.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Product and Services
7.1.4 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Voyager Therapeutics Recent Developments/Updates
7.1.6 Voyager Therapeutics Competitive Strengths & Weaknesses
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Details
7.2.2 Spark Therapeutics Major Business
7.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Product and Services
7.2.4 Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Spark Therapeutics Recent Developments/Updates
7.2.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Gene Therapy in CNS Disorder Product and Services
7.3.4 Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Bluebird Bio Inc.
7.4.1 Bluebird Bio Inc. Details
7.4.2 Bluebird Bio Inc. Major Business
7.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product and Services
7.4.4 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bluebird Bio Inc. Recent Developments/Updates
7.4.6 Bluebird Bio Inc. Competitive Strengths & Weaknesses
7.5 Biogen
7.5.1 Biogen Details
7.5.2 Biogen Major Business
7.5.3 Biogen Gene Therapy in CNS Disorder Product and Services
7.5.4 Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Biogen Recent Developments/Updates
7.5.6 Biogen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy in CNS Disorder Industry Chain
8.2 Gene Therapy in CNS Disorder Upstream Analysis
8.3 Gene Therapy in CNS Disorder Midstream Analysis
8.4 Gene Therapy in CNS Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Therapy in CNS Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy in CNS Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy in CNS Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy in CNS Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Therapy in CNS Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Therapy in CNS Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Therapy in CNS Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy in CNS Disorder Players in 2022
Table 12. World Gene Therapy in CNS Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Therapy in CNS Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy in CNS Disorder Player
Table 15. Gene Therapy in CNS Disorder Market: Company Product Type Footprint
Table 16. Gene Therapy in CNS Disorder Market: Company Product Application Footprint
Table 17. Gene Therapy in CNS Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy in CNS Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Therapy in CNS Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 23. China Based Gene Therapy in CNS Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 29. World Gene Therapy in CNS Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene Therapy in CNS Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene Therapy in CNS Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Therapy in CNS Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Voyager Therapeutics Basic Information, Area Served and Competitors
Table 36. Voyager Therapeutics Major Business
Table 37. Voyager Therapeutics Gene Therapy in CNS Disorder Product and Services
Table 38. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Voyager Therapeutics Recent Developments/Updates
Table 40. Voyager Therapeutics Competitive Strengths & Weaknesses
Table 41. Spark Therapeutics Basic Information, Area Served and Competitors
Table 42. Spark Therapeutics Major Business
Table 43. Spark Therapeutics Gene Therapy in CNS Disorder Product and Services
Table 44. Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Spark Therapeutics Recent Developments/Updates
Table 46. Spark Therapeutics Competitive Strengths & Weaknesses
Table 47. Novartis AG Basic Information, Area Served and Competitors
Table 48. Novartis AG Major Business
Table 49. Novartis AG Gene Therapy in CNS Disorder Product and Services
Table 50. Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis AG Recent Developments/Updates
Table 52. Novartis AG Competitive Strengths & Weaknesses
Table 53. Bluebird Bio Inc. Basic Information, Area Served and Competitors
Table 54. Bluebird Bio Inc. Major Business
Table 55. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product and Services
Table 56. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bluebird Bio Inc. Recent Developments/Updates
Table 58. Biogen Basic Information, Area Served and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Gene Therapy in CNS Disorder Product and Services
Table 61. Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Gene Therapy in CNS Disorder Upstream (Raw Materials)
Table 63. Gene Therapy in CNS Disorder Typical Customers
Table 1. World Gene Therapy in CNS Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy in CNS Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy in CNS Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy in CNS Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Therapy in CNS Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Therapy in CNS Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Therapy in CNS Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy in CNS Disorder Players in 2022
Table 12. World Gene Therapy in CNS Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Therapy in CNS Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy in CNS Disorder Player
Table 15. Gene Therapy in CNS Disorder Market: Company Product Type Footprint
Table 16. Gene Therapy in CNS Disorder Market: Company Product Application Footprint
Table 17. Gene Therapy in CNS Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy in CNS Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Therapy in CNS Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 23. China Based Gene Therapy in CNS Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Therapy in CNS Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Therapy in CNS Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy in CNS Disorder Revenue Market Share (2018-2023)
Table 29. World Gene Therapy in CNS Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene Therapy in CNS Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene Therapy in CNS Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Therapy in CNS Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Voyager Therapeutics Basic Information, Area Served and Competitors
Table 36. Voyager Therapeutics Major Business
Table 37. Voyager Therapeutics Gene Therapy in CNS Disorder Product and Services
Table 38. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Voyager Therapeutics Recent Developments/Updates
Table 40. Voyager Therapeutics Competitive Strengths & Weaknesses
Table 41. Spark Therapeutics Basic Information, Area Served and Competitors
Table 42. Spark Therapeutics Major Business
Table 43. Spark Therapeutics Gene Therapy in CNS Disorder Product and Services
Table 44. Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Spark Therapeutics Recent Developments/Updates
Table 46. Spark Therapeutics Competitive Strengths & Weaknesses
Table 47. Novartis AG Basic Information, Area Served and Competitors
Table 48. Novartis AG Major Business
Table 49. Novartis AG Gene Therapy in CNS Disorder Product and Services
Table 50. Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis AG Recent Developments/Updates
Table 52. Novartis AG Competitive Strengths & Weaknesses
Table 53. Bluebird Bio Inc. Basic Information, Area Served and Competitors
Table 54. Bluebird Bio Inc. Major Business
Table 55. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product and Services
Table 56. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bluebird Bio Inc. Recent Developments/Updates
Table 58. Biogen Basic Information, Area Served and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Gene Therapy in CNS Disorder Product and Services
Table 61. Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Gene Therapy in CNS Disorder Upstream (Raw Materials)
Table 63. Gene Therapy in CNS Disorder Typical Customers
LIST OF FIGURES
Figure 1. Gene Therapy in CNS Disorder Picture
Figure 2. World Gene Therapy in CNS Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy in CNS Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Gene Therapy in CNS Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Therapy in CNS Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy in CNS Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy in CNS Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy in CNS Disorder Markets in 2022
Figure 27. United States VS China: Gene Therapy in CNS Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy in CNS Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Therapy in CNS Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 31. Viral Gene Therapy
Figure 32. Non-viral Gene Therapy
Figure 33. World Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2029)
Figure 34. World Gene Therapy in CNS Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 36. Alzheimer's Disease
Figure 37. Huntington's Disease
Figure 38. Parkinson's Disease
Figure 39. Batten Disease
Figure 40. Gene Therapy in CNS Disorder Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Gene Therapy in CNS Disorder Picture
Figure 2. World Gene Therapy in CNS Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy in CNS Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Therapy in CNS Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Therapy in CNS Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Gene Therapy in CNS Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Therapy in CNS Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Therapy in CNS Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy in CNS Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy in CNS Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy in CNS Disorder Markets in 2022
Figure 27. United States VS China: Gene Therapy in CNS Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy in CNS Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Therapy in CNS Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 31. Viral Gene Therapy
Figure 32. Non-viral Gene Therapy
Figure 33. World Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2029)
Figure 34. World Gene Therapy in CNS Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 36. Alzheimer's Disease
Figure 37. Huntington's Disease
Figure 38. Parkinson's Disease
Figure 39. Batten Disease
Figure 40. Gene Therapy in CNS Disorder Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
